Seizures grow more common in late-stage Alzheimer's and often look subtle rather than convulsive. Signs include brief staring, confusion and small jerks, triggers include the disease itself plus infections and metabolic changes, and doctors often treat even a single unprovoked seizure to protect thinking. Late-stage Alzheimer's means severe disease with loss of speech and need for full-time care. A seizure is abnormal electrical activity in the brain that briefly changes awareness, movement or behavior.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How common are seizures in late Alzheimer's?
- What do seizures look like in dementia?
- What triggers a seizure?
- How do doctors treat seizures in dementia?
- What should caregivers watch for and do?
How common are seizures in late Alzheimer's?
About 10%-22% of people with Alzheimer's dementia have at least one unprovoked seizure in their lifetime, with risk rising in later stages, averaging 6 or more years into the disease, according to the Drugs & Aging review Drugs & Aging review. Late onset does not mean low risk. People with Alzheimer's experience epileptic seizures up to 6.5 times more often than people without dementia, according to the Alzheimer's Association in its AAIC 2019 findings.
Recurrence is higher and first seizure occurs at a younger age. The U.S. National Institute on Aging lists seizures among the signs of severe, late-stage disease, according to its symptoms page. They appear alongside loss of communication and need for full-time care.
What do seizures look like in dementia?
Most seizures in dementia are focal-onset rather than convulsive, according to Forward with Dementia in Australia and JAMA Neurology via GuideStar Eldercare. They cause brief unresponsiveness, amnesia, staring and slow recovery. Common signs include chewing, lip-smacking, hand or arm twitching and hallucinations. Afterward the person may stay confused for a prolonged time.
Family members often mistake these events for dementia worsening. Hidden activity is also common. Vossel and colleagues found subclinical epileptiform activity in 42.4% of Alzheimer's patients with extended EEG plus magnetoencephalography, summarized in Frontiers in Aging Neuroscience. Routine EEG alone often misses it.
What triggers a seizure?
Two types matter. Acute symptomatic seizures follow metabolic disturbances, infections, toxins or seizure-lowering drugs, according to the Expert Review of Neurotherapeutics in 2024. These carry low recurrence risk once the cause clears. Unprovoked seizures come from Alzheimer's neurodegeneration itself.
These carry higher recurrence risk. That distinction guides treatment decisions. Medication review matters because some common drugs lower seizure threshold. Infection, dehydration and metabolic shifts can also provoke an event. Prompt workup helps separate a one-time trigger from ongoing epilepsy.
How do doctors treat seizures in dementia?
European neurology guidelines from 2020 treat a single unprovoked seizure in dementia as structural epilepsy. The reason is practical: untreated seizures can accelerate cognitive decline. Levetiracetam or lamotrigine are favored as well-tolerated first options. Research interest focuses on cognition.
The National Institute on Aging lists a clinical trial of levetiracetam for Alzheimer's-associated epileptiform activity. The goal is to test whether controlling abnormal activity protects memory and thinking. Evaluation is prompt and focused. Doctors confirm the event, look for reversible triggers and weigh daily function, fall risk and drug interactions. Treatment aims for seizure control with the fewest cognitive side effects.
What should caregivers watch for and do?
Do not wait for convulsions. Caregivers should report staring spells, sudden confusion or jerks, according to guidance from the Adult Down Syndrome Center at Advocate Health and the National Institute on Aging.
Early reporting allows faster testing. Bring a written log with dates, duration and exact behaviors. Ask whether any current drug can be changed and whether prompt epilepsy evaluation is needed, since anti-seizure treatment may protect cognition.
- staring spells, blanking out or unresponsiveness lasting seconds to minutes
- sudden confusion, amnesia, chewing, lip-smacking or hand and arm jerks
- new hallucinations, prolonged drowsiness or unusually slow recovery after a spell
- recent infection, metabolic illness or start of a drug that lowers seizure threshold
